Evidence map›Paper›PMID 31680875›Full record

ArticleFrontiers in cellular neuroscience2019

Automated Live-Cell Imaging of Synapses in Rat and Human Neuronal Cultures.

Matthew V Green, Thomas Pengo, Jonathan D Raybuck, Tahmina Naqvi, Hannah M McMullan, Jon E Hawkinson, Ezequiel Marron Fernandez de Velasco, Brian S Muntean, Kirill A Martemyanov, Rachel Satterfield and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Matthew V GreenDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States.
Thomas PengoInformatics Institute, University of Minnesota, Minneapolis, MN, United States.
Jonathan D RaybuckDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States.
Tahmina NaqviInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, United States.
Hannah M McMullanDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States.
Jon E HawkinsonInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, United States.
Ezequiel Marron Fernandez de VelascoDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States.
Brian S MunteanDepartment of Neuroscience, Scripps Research Institute, Jupiter, FL, United States.
Kirill A MartemyanovDepartment of Neuroscience, Scripps Research Institute, Jupiter, FL, United States.
Rachel SatterfieldMax Planck Florida Institute for Neuroscience, Jupiter, FL, United States.
Samuel M YoungDepartment of Anatomy and Cell Biology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, United States.
Stanley A ThayerDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, United States.
University of Minnesota Medical Center · USUniversity of Minnesota · USScripps Research Institute · USMax Planck Florida Institute for Neuroscience · USUniversity of Iowa · US

Funding

HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDSR01DA007304 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THAYER, STANLEY A · 1992 to 2024
$5.0M
Regulation of Synaptic Vesicle Dynamics in the Auditory SystemR01DC014093 · NIDCD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YOUNG, SAMUEL MATTHEW · 2015 to 2024
$3.7M
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicityR33NS087274 · NINDS · UNIVERSITY OF MINNESOTA · PI THAYER, STANLEY A · 2016 to 2017
$1.2M
Molecular Basis of RGS Protein Function in the StriatumK02DA026405 · NIDA · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A. · 2009 to 2019
$1.2M
Scalable assay for drugs to reverse synapse loss during HIV-1 neurotoxicityR21NS087274 · NINDS · UNIVERSITY OF MINNESOTA · PI THAYER, STANLEY A · 2014 to 2015
$464k
Synapse loss induced by HIV-1 proteins in the presence of ART and drugs of abuseR21DA044809 · NIDA · UNIVERSITY OF MINNESOTA · PI THAYER, STANLEY A · 2017 to 2018
$422k
NIDA NIH HHS K02 DA026405NIDA NIH HHS R01 DA007304NIDA NIH HHS R21 DA044809NIDCD NIH HHS R01 DC014093NINDS NIH HHS R21 NS087274NINDS NIH HHS R33 NS087274
6 · The paper itself

Abstract

Synapse loss and dendritic damage correlate with cognitive decline in many neurodegenerative diseases, underlie neurodevelopmental disorders, and are associated with environmental and drug-induced CNS toxicities. However, screening assays designed to measure loss of synaptic connections between live cells are lacking. Here, we describe the design and validation of automated synaptic imaging assay (ASIA), an efficient approach to label, image, and analyze synapses between live neurons. Using viral transduction to express fluorescent proteins that label synapses and an automated computer-controlled microscope, we developed a method to identify agents that regulate synapse number. ASIA is compatible with both confocal and wide-field microscopy; wide-field image acquisition is faster but requires a deconvolution step in the analysis. Both types of images feed into batch processing analysis software that can be run on ImageJ, CellProfiler, and MetaMorph platforms. Primary analysis endpoints are the number of structural synapses and cell viability. Thus, overt cell death is differentiated from subtle changes in synapse density, an important distinction when studying neurodegenerative processes. In rat hippocampal cultures treated for 24 h with 100 μM 2-bromopalmitic acid (2-BP), a compound that prevents clustering of postsynaptic density 95 (PSD95), ASIA reliably detected loss of postsynaptic density 95-enhanced green fluorescent protein (PSD95-eGFP)-labeled synapses in the absence of cell death. In contrast, treatment with 100 μM glutamate produced synapse loss and significant cell death, determined from morphological changes in a binary image created from co-expressed mCherry. Treatment with 3 mM lithium for 24 h significantly increased the number of fluorescent puncta, showing that ASIA also detects synaptogenesis. Proof of concept studies show that cell-specific promoters enable the selective study of inhibitory or principal neurons and that alternative reporter constructs enable quantification of GABAergic or glutamatergic synapses. ASIA can also be used to study synapse loss between human induced pluripotent stem cell (iPSC)-derived cortical neurons. Significant synapse loss in the absence of cell death was detected in the iPSC-derived neuronal cultures treated with either 100 μM 2-BP or 100 μM glutamate for 24 h, while 300 μM glutamate produced synapse loss and cell death. ASIA shows promise for identifying agents that evoke synaptic toxicities and screening for compounds that prevent or reverse synapse loss.

Indexed as

automated microscopyhuman iPSCimage processingsynapse losssynaptogenesisviral transduction

Identifiers

PMID31680875
PMCPMC6811609
OpenAlexW2980794476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.